Emerging science of the human microbiome

References

• Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, et al. An estimation of the number of cells in the human body. Ann Hum Biol 2013; 40:463 - 71; http://dx.doi.org/10.3109/03014460.2013.807878; PMID: 23829164
   PubMed Web of Science ®Google Scholar
• Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci U S A 1998; 95:6578 - 83; http://dx.doi.org/10.1073/pnas.95.12.6578; PMID: 9618454
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science 2005; 307:1915 - 20; http://dx.doi.org/10.1126/science.1104816; PMID: 15790844
   PubMed Web of Science ®Google Scholar
• Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006; 124:837 - 48; http://dx.doi.org/10.1016/j.cell.2006.02.017; PMID: 16497592
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007; 449:804 - 10; http://dx.doi.org/10.1038/nature06244; PMID: 17943116
   PubMed Web of Science ®Google Scholar
• Lederberg J. 'Ome Sweet 'Omics–A Genealogical Treasury of Words. The Scientist 2001; 15
   Google Scholar
• Staley JT, Konopka A. Measurement of in situ activities of nonphotosynthetic microorganisms in aquatic and terrestrial habitats. Annu Rev Microbiol 1985; 39:321 - 46; http://dx.doi.org/10.1146/annurev.mi.39.100185.001541; PMID: 3904603
   PubMed Web of Science ®Google Scholar
• Tringe SG, Hugenholtz P. A renaissance for the pioneering 16S rRNA gene. Curr Opin Microbiol 2008; 11:442 - 6; http://dx.doi.org/10.1016/j.mib.2008.09.011; PMID: 18817891
   PubMed Web of Science ®Google Scholar
• O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7:688 - 93; http://dx.doi.org/10.1038/sj.embor.7400731; PMID: 16819463
   PubMed Web of Science ®Google Scholar
• Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 2008; 6:121 - 31; http://dx.doi.org/10.1038/nrmicro1817; PMID: 18180751
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005; 307:1955 - 9; http://dx.doi.org/10.1126/science.1109051; PMID: 15790854
   PubMed Web of Science ®Google Scholar
• LeBlanc JG, Milani C, de Giori GS, Sesma F, van Sinderen D, Ventura M. Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 2013; 24:160 - 8; http://dx.doi.org/10.1016/j.copbio.2012.08.005; PMID: 22940212
   PubMed Web of Science ®Google Scholar
• Resta SC. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 2009; 587:4169 - 74; http://dx.doi.org/10.1113/jphysiol.2009.176370; PMID: 19596893
   PubMed Web of Science ®Google Scholar
• Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, Lozupone CA, Knight R, Gordon JI. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 2009; 6:279 - 89; http://dx.doi.org/10.1016/j.chom.2009.08.003; PMID: 19748469
   PubMed Web of Science ®Google Scholar
• Beg AA. ComPPARtmentalizing NF-kappaB in the gut. Nat Immunol 2004; 5:14 - 6; http://dx.doi.org/10.1038/ni0104-14; PMID: 14699401
   PubMed Web of Science ®Google Scholar
• Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10:311 - 23; http://dx.doi.org/10.1016/j.chom.2011.10.004; PMID: 22018232
   PubMed Web of Science ®Google Scholar
• Ventura M, Turroni F, Motherway MO, MacSharry J, van Sinderen D. Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria. Trends Microbiol 2012; 20:467 - 76; http://dx.doi.org/10.1016/j.tim.2012.07.002; PMID: 22902802
   PubMed Web of Science ®Google Scholar
• Hardy H, Harris J, Lyon E, Beal J, Foey AD. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 2013; 5:1869 - 912; http://dx.doi.org/10.3390/nu5061869; PMID: 23760057
   PubMed Web of Science ®Google Scholar
• Mitsuoka T, Hidaka H, Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung 1987; 31:427 - 36; http://dx.doi.org/10.1002/food.19870310528; PMID: 3657917
   PubMedGoogle Scholar
• Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, Chiang HC, Hooper LV, Gordon JI. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003; 299:2074 - 6; http://dx.doi.org/10.1126/science.1080029; PMID: 12663928
   PubMed Web of Science ®Google Scholar
• Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013; 501:426 - 9; http://dx.doi.org/10.1038/nature12447; PMID: 23955152
   PubMed Web of Science ®Google Scholar
• Freeland KR, Wilson C, Wolever TM. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 2010; 103:82 - 90; http://dx.doi.org/10.1017/S0007114509991462; PMID: 19664300
   PubMed Web of Science ®Google Scholar
• Wichmann A, Allahyar A, Greiner TU, Plovier H, Lundén GO, Larsson T, Drucker DJ, Delzenne NM, Cani PD, Bäckhed F. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 2013; 14:582 - 90; http://dx.doi.org/10.1016/j.chom.2013.09.012; PMID: 24237703
   PubMed Web of Science ®Google Scholar
• Brestoff JR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 2013; 14:676 - 84; http://dx.doi.org/10.1038/ni.2640; PMID: 23778795
   PubMed Web of Science ®Google Scholar
• Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol 2009; 15:5549 - 57; http://dx.doi.org/10.3748/wjg.15.5549; PMID: 19938193
   PubMed Web of Science ®Google Scholar
• Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem 2003; 278:25481 - 9; http://dx.doi.org/10.1074/jbc.M301403200; PMID: 12711604
   PubMed Web of Science ®Google Scholar
• Patel KK, Stappenbeck TS. Autophagy and intestinal homeostasis. Annu Rev Physiol 2013; 75:241 - 62; http://dx.doi.org/10.1146/annurev-physiol-030212-183658; PMID: 23216414
   PubMed Web of Science ®Google Scholar
• Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569 - 73; http://dx.doi.org/10.1126/science.1241165; PMID: 23828891
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009; 89:147 - 91; http://dx.doi.org/10.1152/physrev.00010.2008; PMID: 19126757
   PubMed Web of Science ®Google Scholar
• Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29:625 - 51; http://dx.doi.org/10.1016/j.femsre.2004.09.003; PMID: 16102595
   PubMed Web of Science ®Google Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab 2013; 17:657 - 69; http://dx.doi.org/10.1016/j.cmet.2013.03.013; PMID: 23602448
   PubMed Web of Science ®Google Scholar
• Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4523 - 30; http://dx.doi.org/10.1073/pnas.1006734107; PMID: 20837534
   PubMed Web of Science ®Google Scholar
• Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 2004; 113:1408 - 18; http://dx.doi.org/10.1172/JCI21025; PMID: 15146238
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, Edwards PA. Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A 2006; 103:1006 - 11; http://dx.doi.org/10.1073/pnas.0506982103; PMID: 16410358
   PubMed Web of Science ®Google Scholar
• Schaap FG. Role of fibroblast growth factor 19 in the control of glucose homeostasis. Curr Opin Clin Nutr Metab Care 2012; 15:386 - 91; http://dx.doi.org/10.1097/MCO.0b013e3283547171; PMID: 22617565
   PubMed Web of Science ®Google Scholar
• Matsubara T, Li F, Gonzalez FJ. FXR signaling in the enterohepatic system. Mol Cell Endocrinol 2013; 368:17 - 29; http://dx.doi.org/10.1016/j.mce.2012.05.004; PMID: 22609541
   PubMed Web of Science ®Google Scholar
• Wang YD, Chen WD, Yu D, Forman BM, Huang W. The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. Hepatology 2011; 54:1421 - 32; http://dx.doi.org/10.1002/hep.24525; PMID: 21735468
   PubMed Web of Science ®Google Scholar
• Maruyama T, Tanaka K, Suzuki J, Miyoshi H, Harada N, Nakamura T, Miyamoto Y, Kanatani A, Tamai Y. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. J Endocrinol 2006; 191:197 - 205; http://dx.doi.org/10.1677/joe.1.06546; PMID: 17065403
   PubMed Web of Science ®Google Scholar
• Sato H, Genet C, Strehle A, Thomas C, Lobstein A, Wagner A, Mioskowski C, Auwerx J, Saladin R. Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochem Biophys Res Commun 2007; 362:793 - 8; http://dx.doi.org/10.1016/j.bbrc.2007.06.130; PMID: 17825251
   PubMed Web of Science ®Google Scholar
• Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005; 329:386 - 90; http://dx.doi.org/10.1016/j.bbrc.2005.01.139; PMID: 15721318
   PubMed Web of Science ®Google Scholar
• Thomas C, Gioiello A, Noriega L, Strehle A, Oury J, Rizzo G, Macchiarulo A, Yamamoto H, Mataki C, Pruzanski M, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009; 10:167 - 77; http://dx.doi.org/10.1016/j.cmet.2009.08.001; PMID: 19723493
   PubMed Web of Science ®Google Scholar
• Lavoie B, Balemba OB, Godfrey C, Watson CA, Vassileva G, Corvera CU, Nelson MT, Mawe GM. Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels. J Physiol 2010; 588:3295 - 305; http://dx.doi.org/10.1113/jphysiol.2010.192146; PMID: 20624794
   PubMed Web of Science ®Google Scholar
• Li T, Holmstrom SR, Kir S, Umetani M, Schmidt DR, Kliewer SA, Mangelsdorf DJ. The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. Mol Endocrinol 2011; 25:1066 - 71; http://dx.doi.org/10.1210/me.2010-0460; PMID: 21454404
   PubMed Web of Science ®Google Scholar
• Vassileva G, Golovko A, Markowitz L, Abbondanzo SJ, Zeng M, Yang S, Hoos L, Tetzloff G, Levitan D, Murgolo NJ, et al. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochem J 2006; 398:423 - 30; http://dx.doi.org/10.1042/BJ20060537; PMID: 16724960
   PubMed Web of Science ®Google Scholar
• Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148:1258 - 70; http://dx.doi.org/10.1016/j.cell.2012.01.035; PMID: 22424233
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280; http://dx.doi.org/10.1371/journal.pbio.0060280; PMID: 19018661
   PubMed Web of Science ®Google Scholar
• Kashyap PC, Marcobal A, Ursell LK, Smits SA, Sonnenburg ED, Costello EK, Higginbottom SK, Domino SE, Holmes SP, Relman DA, et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota. Proc Natl Acad Sci U S A 2013; 110:17059 - 64; http://dx.doi.org/10.1073/pnas.1306070110; PMID: 24062455
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al, MetaHIT Consortium. Enterotypes of the human gut microbiome. Nature 2011; 473:174 - 80; http://dx.doi.org/10.1038/nature09944; PMID: 21508958
   PubMed Web of Science ®Google Scholar
• Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, Clemente JC, Knight R, Heath AC, Leibel RL, et al. The long-term stability of the human gut microbiota. Science 2013; 341:1237439; http://dx.doi.org/10.1126/science.1237439; PMID: 23828941
   PubMed Web of Science ®Google Scholar
• Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694 - 7; http://dx.doi.org/10.1126/science.1177486; PMID: 19892944
   PubMed Web of Science ®Google Scholar
• Vanhoutte T, Huys G, Brandt E, Swings J. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol 2004; 48:437 - 46; http://dx.doi.org/10.1016/j.femsec.2004.03.001; PMID: 19712312
   PubMed Web of Science ®Google Scholar
• Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4578 - 85; http://dx.doi.org/10.1073/pnas.1000081107; PMID: 20668239
   PubMed Web of Science ®Google Scholar
• Gosalbes MJ, Llop S, Vallès Y, Moya A, Ballester F, Francino MP. Meconium microbiota types dominated by lactic acid or enteric bacteria are differentially associated with maternal eczema and respiratory problems in infants. Clin Exp Allergy 2013; 43:198 - 211; http://dx.doi.org/10.1111/cea.12063; PMID: 23331561
   PubMed Web of Science ®Google Scholar
• Moles L, Gómez M, Heilig H, Bustos G, Fuentes S, de Vos W, Fernández L, Rodríguez JM, Jiménez E. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One 2013; 8:e66986; http://dx.doi.org/10.1371/journal.pone.0066986; PMID: 23840569
   PubMed Web of Science ®Google Scholar
• Hu J, Nomura Y, Bashir A, Fernandez-Hernandez H, Itzkowitz S, Pei Z, Stone J, Loudon H, Peter I. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One 2013; 8:e78257; http://dx.doi.org/10.1371/journal.pone.0078257; PMID: 24223144
   PubMed Web of Science ®Google Scholar
• Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N, Knight R. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 2010; 107:11971 - 5; http://dx.doi.org/10.1073/pnas.1002601107; PMID: 20566857
   PubMed Web of Science ®Google Scholar
• Huurre A, Kalliomäki M, Rautava S, Rinne M, Salminen S, Isolauri E. Mode of delivery - effects on gut microbiota and humoral immunity. Neonatology 2008; 93:236 - 40; http://dx.doi.org/10.1159/000111102; PMID: 18025796
   PubMed Web of Science ®Google Scholar
• Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5:e177; http://dx.doi.org/10.1371/journal.pbio.0050177; PMID: 17594176
   PubMed Web of Science ®Google Scholar
• Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4586 - 91; http://dx.doi.org/10.1073/pnas.1000097107; PMID: 20571116
   PubMed Web of Science ®Google Scholar
• Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013; 501:426 - 9; http://dx.doi.org/10.1038/nature12447; PMID: 23955152
   PubMed Web of Science ®Google Scholar
• Ikehara Y, Nishihara S, Yasutomi H, Kitamura T, Matsuo K, Shimizu N, Inada K, Kodera Y, Yamamura Y, Narimatsu H, et al. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol Biomarkers Prev 2001; 10:971 - 7; PMID: 11535550
   PubMed Web of Science ®Google Scholar
• Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. Human susceptibility and resistance to Norwalk virus infection. Nat Med 2003; 9:548 - 53; http://dx.doi.org/10.1038/nm860; PMID: 12692541
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 2003; 278:14112 - 20; http://dx.doi.org/10.1074/jbc.M207744200; PMID: 12562767
   PubMed Web of Science ®Google Scholar
• Hildebrand F, Nguyen TL, Brinkman B, Yunta RG, Cauwe B, Vandenabeele P, Liston A, Raes J. Inflammation-associated enterotypes, host genotype, cage and inter-individual effects drive gut microbiota variation in common laboratory mice. Genome Biol 2013; 14:R4; http://dx.doi.org/10.1186/gb-2013-14-1-r4; PMID: 23347395
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, Affourtit J, Egholm M, Henrissat B, Knight R, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci U S A 2010; 107:7503 - 8; http://dx.doi.org/10.1073/pnas.1002355107; PMID: 20363958
   PubMed Web of Science ®Google Scholar
• Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214; http://dx.doi.org/10.1126/science.1241214; PMID: 24009397
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022 - 3; http://dx.doi.org/10.1038/4441022a; PMID: 17183309
   PubMed Web of Science ®Google Scholar
• Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota’s response to diet in gnotobiotic mice. Science 2011; 333:101 - 4; http://dx.doi.org/10.1126/science.1206025; PMID: 21596954
   PubMed Web of Science ®Google Scholar
• Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, Shah N, Wang C, Magrini V, Wilson RK, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc Natl Acad Sci U S A 2009; 106:5859 - 64; http://dx.doi.org/10.1073/pnas.0901529106; PMID: 19321416
   PubMed Web of Science ®Google Scholar
• Samuel BS, Gordon JI. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 2006; 103:10011 - 6; http://dx.doi.org/10.1073/pnas.0602187103; PMID: 16782812
   PubMed Web of Science ®Google Scholar
• David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559 - 63; http://dx.doi.org/10.1038/nature12820; PMID: 24336217
   PubMed Web of Science ®Google Scholar
• Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995; 108:975 - 82; http://dx.doi.org/10.1016/0016-5085(95)90192-2; PMID: 7698613
   PubMed Web of Science ®Google Scholar
• Calame W, Weseler AR, Viebke C, Flynn C, Siemensma AD. Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner. Br J Nutr 2008; 100:1269 - 75; http://dx.doi.org/10.1017/S0007114508981447; PMID: 18466655
   PubMed Web of Science ®Google Scholar
• Costabile A, Kolida S, Klinder A, Gietl E, Bäuerlein M, Frohberg C, Landschütze V, Gibson GR. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 2010; 104:1007 - 17; http://dx.doi.org/10.1017/S0007114510001571; PMID: 20591206
   PubMed Web of Science ®Google Scholar
• Elli M, Cattivelli D, Soldi S, Bonatti M, Morelli L. Evaluation of prebiotic potential of refined psyllium (Plantago ovata) fiber in healthy women. J Clin Gastroenterol 2008; 42:Suppl 3 Pt 2 S174 - 6; http://dx.doi.org/10.1097/MCG.0b013e31817f183a; PMID: 18685505
   PubMed Web of Science ®Google Scholar
• Lefranc-Millot C, Guérin-Deremaux L, Wils D, Neut C, Miller LE, Saniez-Degrave MH. Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE®, a soluble fibre with prebiotic properties, may be beneficial for health. J Int Med Res 2012; 40:211 - 24; http://dx.doi.org/10.1177/147323001204000122; PMID: 22429361
   PubMed Web of Science ®Google Scholar
• Ramnani P, Gaudier E, Bingham M, van Bruggen P, Tuohy KM, Gibson GR. Prebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study. Br J Nutr 2010; 104:233 - 40; http://dx.doi.org/10.1017/S000711451000036X; PMID: 20187995
   PubMed Web of Science ®Google Scholar
• Whelan K. Mechanisms and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management of digestive disorders. Proc Nutr Soc 2013; 72:288 - 98; http://dx.doi.org/10.1017/S0029665113001262; PMID: 23680358
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334:105 - 8; http://dx.doi.org/10.1126/science.1208344; PMID: 21885731
   PubMed Web of Science ®Google Scholar
• Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, Otto W, Rojo D, Bargiela R, von Bergen M, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2013; 62:1591 - 601; http://dx.doi.org/10.1136/gutjnl-2012-303184; PMID: 23236009
   PubMed Web of Science ®Google Scholar
• Hu Y, Yang X, Qin J, Lu N, Cheng G, Wu N, Pan Y, Li J, Zhu L, Wang X, et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 2013; 4:2151; http://dx.doi.org/10.1038/ncomms3151; PMID: 23877117
   PubMed Web of Science ®Google Scholar
• Ng KM, Ferreyra JA, Higginbottom SK, Lynch JB, Kashyap PC, Gopinath S, Naidu N, Choudhury B, Weimer BC, Monack DM, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013; 502:96 - 9; http://dx.doi.org/10.1038/nature12503; PMID: 23995682
   PubMed Web of Science ®Google Scholar
• Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev 2011; 241:241 - 59; http://dx.doi.org/10.1111/j.1600-065X.2011.01017.x; PMID: 21488901
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota?. Nat Rev Microbiol 2009; 7:887 - 94; http://dx.doi.org/10.1038/nrmicro2245; PMID: 19898491
   PubMed Web of Science ®Google Scholar
• Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328:228 - 31; http://dx.doi.org/10.1126/science.1179721; PMID: 20203013
   PubMed Web of Science ®Google Scholar
• Frazão JB, Errante PR, Condino-Neto A. Toll-like receptors’ pathway disturbances are associated with increased susceptibility to infections in humans. Arch Immunol Ther Exp (Warsz) 2013; 61:427 - 43; http://dx.doi.org/10.1007/s00005-013-0243-0; PMID: 24057516
   PubMed Web of Science ®Google Scholar
• Belkaid Y, Naik S. Compartmentalized and systemic control of tissue immunity by commensals. Nat Immunol 2013; 14:646 - 53; http://dx.doi.org/10.1038/ni.2604; PMID: 23778791
   PubMed Web of Science ®Google Scholar
• Brown EM, Sadarangani M, Finlay BB. The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 2013; 14:660 - 7; http://dx.doi.org/10.1038/ni.2611; PMID: 23778793
   PubMed Web of Science ®Google Scholar
• Chu H, Mazmanian SK. Innate immune recognition of the microbiota promotes host-microbial symbiosis. Nat Immunol 2013; 14:668 - 75; http://dx.doi.org/10.1038/ni.2635; PMID: 23778794
   PubMed Web of Science ®Google Scholar
• Kamada N, Chen GY, Inohara N, Núñez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14:685 - 90; http://dx.doi.org/10.1038/ni.2608; PMID: 23778796
   PubMed Web of Science ®Google Scholar
• Weinstock GM. Genomic approaches to studying the human microbiota. Nature 2012; 489:250 - 6; http://dx.doi.org/10.1038/nature11553; PMID: 22972298
   PubMed Web of Science ®Google Scholar
• Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012; 4:1095 - 119; http://dx.doi.org/10.3390/nu4081095; PMID: 23016134
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Fåk F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, Bäckhed F, Nielsen J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 2012; 3:1245; http://dx.doi.org/10.1038/ncomms2266; PMID: 23212374
   PubMed Web of Science ®Google Scholar
• Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012; 490:55 - 60; http://dx.doi.org/10.1038/nature11450; PMID: 23023125
   PubMed Web of Science ®Google Scholar
• Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5:e9085; http://dx.doi.org/10.1371/journal.pone.0009085; PMID: 20140211
   PubMed Web of Science ®Google Scholar
• Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al, MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541 - 6; http://dx.doi.org/10.1038/nature12506; PMID: 23985870
   PubMed Web of Science ®Google Scholar
• Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 2008; 105:13580 - 5; http://dx.doi.org/10.1073/pnas.0804437105; PMID: 18757757
   PubMed Web of Science ®Google Scholar
• Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, Ballet V, Claes K, Van Immerseel F, Verbeke K, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63:1275 - 83; http://dx.doi.org/10.1136/gutjnl-2013-304833; PMID: 24021287
   PubMed Web of Science ®Google Scholar
• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347:911 - 20; http://dx.doi.org/10.1056/NEJMra020100; PMID: 12239261
   PubMed Web of Science ®Google Scholar
• Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, et al, ANR MicroObes consortium. Dietary intervention impact on gut microbial gene richness. Nature 2013; 500:585 - 8; http://dx.doi.org/10.1038/nature12480; PMID: 23985875
   PubMed Web of Science ®Google Scholar
• Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al, MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59 - 65; http://dx.doi.org/10.1038/nature08821; PMID: 20203603
   PubMed Web of Science ®Google Scholar
• Lepage P, Häsler R, Spehlmann ME, Rehman A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Doré J, Raedler A, et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011; 141:227 - 36; http://dx.doi.org/10.1053/j.gastro.2011.04.011; PMID: 21621540
   PubMed Web of Science ®Google Scholar
• Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, Nalin R, Jarrin C, Chardon P, Marteau P, et al. Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 2006; 55:205 - 11; http://dx.doi.org/10.1136/gut.2005.073817; PMID: 16188921
   PubMed Web of Science ®Google Scholar
• Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621 - 6; http://dx.doi.org/10.1038/nature11400; PMID: 22914093
   PubMed Web of Science ®Google Scholar
• Behnsen J, Deriu E, Sassone-Corsi M, Raffatellu M. Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med 2013; 3:a010074; http://dx.doi.org/10.1101/cshperspect.a010074; PMID: 23457295
   PubMed Web of Science ®Google Scholar
• Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, Sherman PM, Mayer EA. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62:787 - 96; http://dx.doi.org/10.1136/gutjnl-2012-302504; PMID: 23474420
   PubMed Web of Science ®Google Scholar
• Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 2013; 29:184 - 9; http://dx.doi.org/10.1097/MOG.0b013e32835d7bba; PMID: 23286925
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 2004; 101:15718 - 23; http://dx.doi.org/10.1073/pnas.0407076101; PMID: 15505215
   PubMed Web of Science ®Google Scholar
• Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, Barbu V, Humbert L, Despras G, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 2013; 62:531 - 9; http://dx.doi.org/10.1136/gutjnl-2012-302578; PMID: 22993202
   PubMed Web of Science ®Google Scholar
• Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:513 - 20, e246-7; http://dx.doi.org/10.1111/j.1365-2982.2012.01893.x; PMID: 22356587
   PubMed Web of Science ®Google Scholar
• Ogilvie LA, Jones BV. Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?. Gut 2012; 61:1642 - 3; http://dx.doi.org/10.1136/gutjnl-2012-302137; PMID: 22490526
   PubMed Web of Science ®Google Scholar
• Welters CF, Heineman E, Thunnissen FB, van den Bogaard AE, Soeters PB, Baeten CG. Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 2002; 45:621 - 7; http://dx.doi.org/10.1007/s10350-004-6257-2; PMID: 12004211
   PubMed Web of Science ®Google Scholar
• Wong JM, Kendall CW, de Souza R, Emam A, Marchie A, Vidgen E, Holmes C, Jenkins DJ. The effect on the blood lipid profile of soy foods combined with a prebiotic: a randomized controlled trial. Metabolism 2010; 59:1331 - 40; http://dx.doi.org/10.1016/j.metabol.2009.12.017; PMID: 20096897
   PubMed Web of Science ®Google Scholar
• Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr 2010; 64:146 - 52; http://dx.doi.org/10.1038/ejcn.2009.120; PMID: 19756029
   PubMed Web of Science ®Google Scholar
• Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009; 29:508 - 18; http://dx.doi.org/10.1111/j.1365-2036.2008.03911.x; PMID: 19053980
   PubMed Web of Science ®Google Scholar
• Parisi GC, Zilli M, Miani MP, Carrara M, Bottona E, Verdianelli G, Battaglia G, Desideri S, Faedo A, Marzolino C, et al. High-fiber diet supplementation in patients with irritable bowel syndrome (IBS): a multicenter, randomized, open trial comparison between wheat bran diet and partially hydrolyzed guar gum (PHGG). Dig Dis Sci 2002; 47:1697 - 704; http://dx.doi.org/10.1023/A:1016419906546; PMID: 12184518
   PubMed Web of Science ®Google Scholar
• Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, Codelli JA, Chow J, Reisman SE, Petrosino JF, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013; 155:1451 - 63; http://dx.doi.org/10.1016/j.cell.2013.11.024; PMID: 24315484
   PubMed Web of Science ®Google Scholar
• Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013; 2:e01202; http://dx.doi.org/10.7554/eLife.01202; PMID: 24192039
   PubMed Web of Science ®Google Scholar
• Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, McGilvray ID, Allard JP. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013; 58:120 - 7; http://dx.doi.org/10.1002/hep.26319; PMID: 23401313
   PubMed Web of Science ®Google Scholar
• Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2013; 11:868 - 75, e1-3; http://dx.doi.org/10.1016/j.cgh.2013.02.015; PMID: 23454028
   PubMed Web of Science ®Google Scholar
• Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O’Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol 2006; 101:1581 - 90; http://dx.doi.org/10.1111/j.1572-0241.2006.00734.x; PMID: 16863564
   PubMed Web of Science ®Google Scholar
• Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics 2005; 115:5 - 9; PMID: 15629974
   PubMed Web of Science ®Google Scholar
• Cleusix V, Lacroix C, Vollenweider S, Le Blay G. Glycerol induces reuterin production and decreases Escherichia coli population in an in vitro model of colonic fermentation with immobilized human feces. FEMS Microbiol Ecol 2008; 63:56 - 64; http://dx.doi.org/10.1111/j.1574-6941.2007.00412.x; PMID: 18028400
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr 2012; 66:1234 - 41; http://dx.doi.org/10.1038/ejcn.2012.126; PMID: 22990854
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 2012; 107:1505 - 13; http://dx.doi.org/10.1017/S0007114511004703; PMID: 22067612
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Ganopolsky JG, Sulemankhil I, Ghali P, Prakash S. Improvement of gastrointestinal health status in subjects consuming Lactobacillus reuteri NCIMB 30242 capsules: a post-hoc analysis of a randomized controlled trial. Expert Opin Biol Ther 2013; 13:1643 - 51; http://dx.doi.org/10.1517/14712598.2013.833601; PMID: 24074303
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Prakash S. Letter to the editor regarding the report of Duboc et al: Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease. Gut 2013; 62:654 - 5; http://dx.doi.org/10.1136/gutjnl-2012-303867; PMID: 23148122
   PubMed Web of Science ®Google Scholar
• Jones ML, Martoni CJ, Prakash S. Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: a post hoc analysis of a randomized controlled trial. J Clin Endocrinol Metab 2013; 98:2944 - 51; http://dx.doi.org/10.1210/jc.2012-4262; PMID: 23609838
   PubMed Web of Science ®Google Scholar
• Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006; 149:367 - 72; http://dx.doi.org/10.1016/j.jpeds.2006.04.053; PMID: 16939749
   PubMed Web of Science ®Google Scholar
• McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812 - 22; http://dx.doi.org/10.1111/j.1572-0241.2006.00465.x; PMID: 16635227
   PubMed Web of Science ®Google Scholar
• Szymański H, Pejcz J, Jawień M, Chmielarczyk A, Strus M, Heczko PB. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains--a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006; 23:247 - 53; http://dx.doi.org/10.1111/j.1365-2036.2006.02740.x; PMID: 16393304
   PubMed Web of Science ®Google Scholar
• Hickson M, D’Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, Bulpitt CJ. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ 2007; 335:80; http://dx.doi.org/10.1136/bmj.39231.599815.55; PMID: 17604300
   PubMed Web of Science ®Google Scholar
• Guandalini S. Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011; 45:Suppl S149 - 53; http://dx.doi.org/10.1097/MCG.0b013e3182257e98; PMID: 21992955
   PubMed Web of Science ®Google Scholar
• Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; CD003048; PMID: 21069673
   PubMedGoogle Scholar
• Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y. Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 2008; 135:568 - 79; http://dx.doi.org/10.1053/j.gastro.2008.04.017; PMID: 18570896
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J, Lukás M, Fixa B, Kascák M, Kamm MA, Weismueller J, Beglinger C, Stolte M, et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53:1617 - 23; http://dx.doi.org/10.1136/gut.2003.037747; PMID: 15479682
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2010; 105:2218 - 27; http://dx.doi.org/10.1038/ajg.2010.218; PMID: 20517305
   PubMed Web of Science ®Google Scholar
• Sood A, Midha V, Makharia GK, Ahuja V, Singal D, Goswami P, Tandon RK. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol 2009; 7:1202 - 9, e1; http://dx.doi.org/10.1016/j.cgh.2009.07.016; PMID: 19631292
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003; 124:1202 - 9; http://dx.doi.org/10.1016/S0016-5085(03)00171-9; PMID: 12730861
   PubMed Web of Science ®Google Scholar
• Arthur JC, Gharaibeh RZ, Uronis JM, Perez-Chanona E, Sha W, Tomkovich S, Mühlbauer M, Fodor AA, Jobin C. VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci Rep 2013; 3:2868; http://dx.doi.org/10.1038/srep02868; PMID: 24100376
   PubMed Web of Science ®Google Scholar